MedPath

Mundipharma (China) Pharmaceutical Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Buprenorphine Transdermal Patches Pharmacokinetic Study

Phase 1
Conditions
Chronic Pain
Interventions
First Posted Date
2019-06-05
Last Posted Date
2019-06-05
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
45
Registration Number
NCT03975010
Locations
🇨🇳

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China

A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain

First Posted Date
2019-05-30
Last Posted Date
2019-06-11
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
194
Registration Number
NCT03967327
Locations
🇨🇳

The 81st hospital of the people's liberation army, Nanjing, China

OTR Tablet 10 mg Fasted-state Bioequivalence Study

Phase 1
Completed
Conditions
Chronic Pain
Interventions
First Posted Date
2018-01-18
Last Posted Date
2020-01-31
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
24
Registration Number
NCT03403504
Locations
🇨🇳

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China

OTR Tablet 40 mg Fed-state Bioequivalence Study

Phase 1
Completed
Conditions
Chronic Pain
Interventions
First Posted Date
2018-01-12
Last Posted Date
2019-11-15
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
42
Registration Number
NCT03398330
Locations
🇨🇳

Xiangya Hospital of Central South University, Changsha, Hunan, China

OTR Tablet 40 mg Fasted-state Bioequivalence Study

Phase 1
Completed
Conditions
Chronic Pain
Interventions
First Posted Date
2018-01-12
Last Posted Date
2020-01-31
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
38
Registration Number
NCT03398278
Locations
🇨🇳

West Hospital, Sichuan University, Chengdu, Sichuan, China

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Phase 3
Conditions
Asthma
Interventions
Drug: Fluticasone/ Formoterol
First Posted Date
2018-01-02
Last Posted Date
2019-04-29
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
330
Registration Number
NCT03387241
Locations
🇨🇳

China-Japanese Friendship Hospital, Beijing, Beijing, China

A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL

Phase 3
Completed
Conditions
Refractory Peripheral T-Cell Lymphoma
Relapsed T-Cell Lymphoma
Interventions
Dietary Supplement: Vitamin B12 and folic acid
First Posted Date
2017-11-21
Last Posted Date
2019-10-01
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
85
Registration Number
NCT03349333
Locations
🇨🇳

Beijing Cancer Hospital, Beijing, China

OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients

Phase 1
Completed
Conditions
Chronic Pain
Interventions
Drug: OXN PR tablet
First Posted Date
2016-08-26
Last Posted Date
2019-07-17
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
30
Registration Number
NCT02880475
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain

Phase 2
Completed
Conditions
Herpes Zoster Pain
Interventions
First Posted Date
2015-05-22
Last Posted Date
2017-11-14
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
243
Registration Number
NCT02452112
Locations
🇨🇳

First affiliated hospital of Chongqing medical university, Chongqing, China

🇨🇳

The first affiliated hospital of Dalian university, Dalian, China

🇨🇳

General hospital of Tianjin medical university, Tianjin, China

and more 18 locations

Targin for Non-cancer Pain

Phase 3
Completed
Conditions
Non Cancer Pain
Interventions
Drug: Oxycodone/naloxone prolonged release tablets
First Posted Date
2013-08-07
Last Posted Date
2017-11-14
Lead Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Target Recruit Count
230
Registration Number
NCT01918098
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, China

🇨🇳

The first affiliated hospital of Bengbu medical collage, Bengbu, China

🇨🇳

West China Hospital, Chengdu, China

and more 28 locations
© Copyright 2025. All Rights Reserved by MedPath